title: Taking control of compliance.
abstract: The cost of biologic therapies adds urgency to the need to develop realistic compliance strategies. By engaging and educating both the physician and patient, some MCOs are working hard to address at what has always been a complicated and formidable issue.
authors: Scott
authors: S
authors: Kober